We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Announces Guidance to Help Industry Evaluate Test Results
FDA Announces Guidance to Help Industry Evaluate Test Results
October 13, 2006
The FDA is issuing new guidance on investigating out-of-specification (OOS) results that fall outside the acceptance criteria established in drug applications, drug master files, official compendia or by the manufacturer in an effort to help pharma manufacturers evaluate test results.